Bio-Techne's total assets for Q3 2026 were $2.55B, an increase of 1.11% from the previous quarter. TECH total liabilities were $465.30M for the fiscal quarter, a -9.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.